The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor ...

BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...

Revive Therapeutics (RVVTF) it has entered into an asset purchase agreement dated March 31 with DiagnaMed to acquire the full rights to ...

Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ...